Cynata Therapeutics Limited (ASX:CYP) Treats First Patient in Kidney Transplant Trial
Cynata Therapeutics (ASX:CYP) has successfully treated its first patient in a kidney transplant clinical trial with CYP-001.
Cynata Therapeutics (ASX:CYP) has successfully treated its first patient in a kidney transplant clinical trial with CYP-001.
Gratifii Limited (ASX: GTI) announces significant growth and market expansion following key acquisitions and strategic partnerships.
Vinyl Group (ASX:VNL) has announced their acquisition of Concrete Playground for $5 million, enhancing their EBITDA and accelerating cash flow.
Buxton Resources Ltd reports significant high-grade graphite results at Graphite Bull, anticipating further resource growth.
Lachlan Star Limited (ASX: LSA) reports significant copper intercepts from its Basin Creek drilling program.
Metals Australia (ASX:MLS) announces progress with project approvals and advancements in its Australian asset portfolio.
Neal Barclay will step down as CEO of Meridian Energy, with Mike Roan appointed as his successor effective June 2025.
Element 25 Limited announces significant expansion at Butcherbird Mine and the development of a US refinery for sustainable manganese supply.
Weebit Nano Ltd (ASX:WBT) addresses ASX compliance breaches and reaffirms commitment to corporate governance standards.
OzAurum Resources Limited (ASX:OZM) has requested a trading halt pending a capital raising announcement.